Literature DB >> 1350352

A ketamine-induced rat model of tardive dyskinesia.

L A Marco1, R S Joshi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1350352     DOI： 10.1016/0301-0082(92)90042-d

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN： 0301-0082            Impact factor:   11.685


× No keyword cloud information.
  4 in total

1.  Inhibition by memantine of the development of persistent oral dyskinesias induced by long-term haloperidol treatment of rats.

Authors:  O A Andreassen; T O Aamo; H A Jøorgensen
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

2.  Ketamine activates breathing and abolishes the coupling between loss of consciousness and upper airway dilator muscle dysfunction.

Authors:  Matthias Eikermann; Martina Grosse-Sundrup; Sebastian Zaremba; Mark E Henry; Edward A Bittner; Ulrike Hoffmann; Nancy L Chamberlin
Journal:  Anesthesiology       Date:  2012-01       Impact factor: 7.892

3.  Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.

Authors:  Josep Dalmau; Amy J Gleichman; Ethan G Hughes; Jeffrey E Rossi; Xiaoyu Peng; Meizan Lai; Scott K Dessain; Myrna R Rosenfeld; Rita Balice-Gordon; David R Lynch
Journal:  Lancet Neurol       Date:  2008-10-11       Impact factor: 44.182

Review 4.  Clinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directions.

Authors:  James Varley; Angela Vincent; Sarosh R Irani
Journal:  J Neurol       Date:  2014-12-10       Impact factor: 4.849
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.